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ScienceDirectThe POT family of membrane transporters use the inwardly
directed proton electrochemical gradient to drive the uptake of
essential nutrients into the cell. Originally discovered in
bacteria, members of the family have been found in all
kingdoms of life except the archaea. A remarkable feature of
the family is their diverse substrate promiscuity. Whereas in
mammals and bacteria they are predominantly di- and tri-
peptide transporters, in plants the family has diverged to
recognize nitrate, plant defence compounds and hormones.
This promiscuity has led to the development of peptide-based
pro-drugs that use PepT1 and PepT2, the mammalian
homologues, to improve oral drug delivery. Recent crystal
structures from bacterial and plant members of the family have
revealed conserved features of the ligand-binding site and
provided insights into post-translational regulation. Here I
review the current understanding of transport, ligand
promiscuity and regulation within the POT family.
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Introduction
Peptide transport is an important route for the cellular
acquisition of nitrogen from the environment [1,2]. In
animals and bacteria the POT family play an important
role in the uptake of peptides for both metabolism and
growth [3,4]. In plants however the POT family, also
known as the NPF or NRT1/PTR family, have evolved
to recognize a more diverse range of molecules [5]. These
include nitrate for metabolism, glucosinolates for seed
defense and phytohormones for growth and developmental
control [6–8]. POT family transporters therefore representwww.sciencedirect.com one of the most promiscuous nutrient transport systems in
biology.
The POT family was first identified and cloned from
Lactococcus lactis in the 1990s and shown to couple di- and
tri-peptide uptake to the inwardly directed proton elec-
trochemical gradient [9,10]. Following this discovery,
related proteins were identified in mammalian brush
border and renal membranes and named PepT1 and
PepT2 respectively [11,12]. Intriguingly none have
been discovered in archeal species, possibly due to the
lack of peptides in harsh environments or efficient amino
acid uptake systems negating their use in this kingdom.
Interest in the mammalian members increased substan-
tially following the discovery that both PepT1 and PepT2
are able to recognize and transport a large number of
orally administered drug molecules, including beta-lac-
tam antibiotics, antiviral and anticancer drugs [13,14,15].
In later studies it became clear that PepT1 and PepT2 are
important mediators of intestinal and renal drug absorp-
tion and distribution [16].
Biochemically POT family transporters represent a num-
ber of unique puzzles. Principal among these is how
ligand promiscuity evolved within a single binding site
and how transport is linked to proton movement. Recent
structural and biochemical studies on several pro- and
eukaryotic transporters have played a major role in
addressing this question and in this short review I will
focus on the molecular basis for promiscuity and regula-
tion.
Alternating access and the role of salt bridges
The POT family belongs to the Major Facilitator Super-
family of secondary active transporters [17]. The first
crystal structure was determined in 2011, from the bacte-
rium Shewanella oniedensis, PepTSo (Figure 1a) [18
].
There are now five additional structures of bacterial
POT family transporters [19,20,21,22,23] all of
which reveal the canonical 12 TM MFS fold, with two
additional helices (A & B) inserted between the two six
helix bundles (1-6; 7-12). PepTSo was trapped in an
inward occluded conformation and allowed the identifi-
cation of the extracellular and intracellular gate helices
that control access to a central peptide-binding site
(Figure 1b). Later structures of POT transporters from
Streptococcus thermophilus (PepTSt) [19
] and Geobacillus
kaustophilus (GkPOT) [20] further identified two pairs
of salt bridge interactions that appeared to mediate the
opening and closure of these gates in response to protonCurrent Opinion in Structural Biology 2017, 45:17–24
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Structure of POT family transporters and transport mechanism. (a) Crystal structure of PepTSo (PDB:2XUT) showing the core 12 TM domains
arranged equally into an N- and C-terminal bundle and the additional helical hairpin, HA & HB, inserted between TM6 and TM7. (b) Current model
of proton coupled transport by the POT family. Transport is predominantly controlled through the opening and closing of two gates that sit on
either side of a central binding site. The gates are made helices 1,2,4,5 from the N-terminal bundle and 7,8,10,11 from the C-terminal bundle. In
many POT family members salt bridge interactions are seen coordinating the open/closed state of the gates. Proton binding/release from
conserved proton binding sites act to drive the transport cycle in the forward direction, thereby concentrating peptides inside the cell.and peptide binding. Using a combination of proton
driven and counterflow transport assays a conserved
ExxER/K motif on TMs 1 & 4 and conserved acidic
residues on TM7 and TM10 were identified as important
sites of proton/peptide binding [19,20,24,25]. Based on
these studies a model for alternating access transport by
the POT family was proposed (Figure 1b) [26], which is
consistent with other secondary active transporters [27].
This suggests that transport is initiated through the
binding of protons to both the ExxER/K and TM7
carboxylate in the outward open conformation. Peptide
entry causes a large conformation change in the gate
helices such that the extracellular gate closes to occlude
the peptide. In this state proton movement from the
extracellular gate salt bridge to the intracellular gate saltCurrent Opinion in Structural Biology 2017, 45:17–24 bridge facilitates opening of the intracellular gate and
release of peptide and protons into the interior of the cell.
Resetting of the cycle is likely the rate-determining step
and involves reforming the intracellular gate salt bridge,
thereby closing the intracellular gate and subsequent
opening of the extracellular gate to accept peptide. This
model makes the assumption that the main movements in
a POT family transporter are made by the eight helices
that form the core of the transporter, TMs 1,2,4,5 and
7,8,10,11 with the remaining four helices, TMs 3,6 and
9,12 acting as scaffolds to coordinate and possibly regulate
the gate helices [28]. Strict coupling must occur through
the ability of the bound ligand to coordinate the proton
relay, although precise details of this mechanism still
remain to be determined.www.sciencedirect.com
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Specificity pockets coordinate peptide binding. (a) Crystal structure of PepTSt shown in the plane of the membrane with the di-peptide Ala-Phe
(PDB:4D2C) (yellow) and tri-peptide Ala-Ala-Ala (PDB:4D2D) (orange) shown as sticks. (b) Close up view of the specificity pockets formed around
the Ala-Phe peptide. (c) Schematic detailing the interactions made to the Ala-Phe peptide shown in B. (d) Equivalent view of (b) in PepTSo2
(PDB:4TPJ), showing the specificity pockets identified in this POT family transporter. The Ala-Phe peptide from PepTSt is shown overlaid in grey.Peptide recognition is achieved through
specificity pockets
Recently three bacterial POT family members have been
crystallised in complex with physiological peptides
[29,30]. PepTSt was crystallised in complex L-ala-
L-phe (AF) and L-ala-L-ala-L-ala (AAA)
(Figure 2a). The peptides can be seen sitting in the
central peptide-binding site observed previously for
PepTSo and GkPOT. GkPOT was captured with the
antibacterial peptide alafosfalin and was recently
reviewed [26], so will not be discussed further here.
The PepTSt structures however revealed four distinct
regions of the binding site that accommodate the peptides
(Figure 2b). There is the polar pocket, which forms
around the side chain of the first amino acid and com-
posed mostly of asparagine, glutamine and serine side
chains. The phenyl group of the second amino acid can be
seen accommodated in a hydrophobic pocket, formed by
the movement of the C-terminal helices towards the
peptide. A movement previously observed in the struc-
ture of PepTSt [19
]. Clamping the peptide at either end
are the conserved acidic and basic charges of the intra-
cellular gate salt bridge, R26 and K126, which also formwww.sciencedirect.com part of the polar pocket and E400, the conserved acidic
group on TM10 (Figure 2c). Interestingly, an acidic patch
of residues that contains the conserved carboxylic group
on TM7 does not interact with the AF peptide, but as
discussed below, interacts with the AAA tri-peptide in
PepTSt. These structures and additional studies [23
,25]
clearly support an important role for electrostatic inter-
actions in orientating the peptide.
At a similar time the structures of PepTSo2 in complex
with three peptides were also reported [30]. In this
study the transporter was captured with L-peptides AY,
AYA and AAA. The authors identified three pockets that
accommodated the peptides (Figure 2d). As all three
peptides bound in the same manner only one is shown
here, with the AF peptide of PepTSt shown for compari-
son. Comparing Figure 2b and d it is easy to see the
similarities between the two structures with respect to the
polar pocket in PepTSt and pocket 1 in PepTSo2, and
likewise the ExxER/K pocket and the top half of pocket
3. However, differences do exist and the most notable is
the absence of the hydrophobic pocket in the PepTSo2
structures. However, both pocket 3 and pocket 2 inCurrent Opinion in Structural Biology 2017, 45:17–24
20 MembranesPepTSo2 contain several large hydrophobic groups and it
may simply be that in PepTSo2 the hydrophobic pocket is
not as clearly defined in this transporter.
The nature of the binding site in these two transporters
supports a model for peptide recognition that relies
heavily on interactions with the side chains of the
ligand, rather than relying solely on interactions with
the amino and carboxy termini as previously proposed
[31,18]. The importance of the polar pocket in deter-
mining peptide specificity in PepTSt was recently
demonstrated through computational docking and sup-
ported by in vitro transport assays [32]. The impor-
tance of specificity pockets would also explain the
preferences for different peptides observed between
members of the POT family that have been reported
[33,34,19,20,23,30].Figure 3
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polyspecificity
The co-crystal structure of PepTSt in complex with AAA
revealed the tri-peptide sitting in a vertical position, as
opposed to the more horizontal orientation observed for
the AF peptide in PepTSt and the AYA, AAA peptides in
PepTSo2 (Figures 2a and 3a). The interactions between
PepTSt and the AAA peptide were also different, mainly
contributed by the conserved tyrosines on TM1 (Y29,
Y30) and the glutamate on TM7 (E300) [29]. Unlike the
AF peptide, which we could see interacting with the
intracellular gate salt bridge residues, the AAA peptide
was clearly interacting more with the extracellular gate
helices (Figure 3a). However, although the orientation of
the two peptides was different, the direction into which
the side chains were pointing between them is very
similar. Indeed, it seems likely that the same specificity(b)
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Peptide transport via the POT family Newstead 21pockets observed for the AF peptide will accommodate
the first and second side chains from a tri-peptide, with a
third pocket opening up to accommodate the final resi-
due. Indeed, selected mutations in these pockets in
PepTSt supported this hypothesis [29
,32].
The different positions occupied by both the AF and AAA
peptides in the binding site of PepTSt suggested some-
thing rather interesting. If the transporter could interact
with peptides in different ways, could it also transport
them with different numbers of protons? The transport
model in Figure 1b shows two protons per peptide, which
was suggested for PepT2, although similar studies in
PepT1 suggest a proton:peptide stoichiometry of 1:1
for di-peptides [35,36]. It is unclear if this stoichiometry
holds for tri-peptides and drug molecules.
Using a reconstituted liposome based transport assay the
stoichiometry of proton:peptide transport for PepTSt was
however determined to be 3:1 for tri-peptides and 5-6:1
for di-peptides [37]. It is likely, given the similar orien-
tation of side chains observed for the AF and AAA
peptides in PepTSt that both di- and tri-peptides are
‘handled’ in similar ways, using the specificity pockets
identified, but are clearly moved across the membrane
with different numbers of protons. This result creates a
surprising realization, that PepTSt has two different
mechanisms for transporting peptides.
This result also suggested that given the same pH gradi-
ent across a membrane, di-peptides should be concen-
trated to higher steady state levels than tri-peptides.
Indeed, this was found to be the case, with di-alanine
being concentrated to far higher levels than tri-alanine for
the same pH gradient (Figure 3c). PepTSt can therefore
not only biochemically select for peptides based on side
chain interactions with the specificity pockets but also
thermodynamically ‘select’ di-peptides over tri-peptides
due to its ability to concentrate these several fold higher
than tri-peptides in the cell. This flexibility in binding
and stoichiometry would be extremely difficult to achieve
in a sodium-coupled system and may explain why peptide
transport has remained proton coupled in bacteria, plants,
fungi and mammals [4].
POT family: regulation and adaptation
The crystal structure of the plant nitrate transporter
NRT1.1 allowed for a unique insight into how this family
has changed substrate specificity [38,39]. The indi-
vidual specificity pockets that we observed for the side
chains in the peptide transporters have disappeared,
being replaced by one larger pocket formed by TM1
and 7 (Figure 4a). Remarkably the binding site in
NRT1.1 is actually larger than observed in the bacterial
peptide transporters, even though we observe only a
single nitrate molecule in the binding site. A significant
change in the binding site appears to be the replacementwww.sciencedirect.com of the acidic patch with a histidine on TM7 (His356).
Given the pKa of histdine (6.0), it is likely this requires
protonation to form a favorable electrostatic interaction
with nitrate under physiological conditions. What is more
interesting however is that all of the intracellular gate
machinery remains intact in NRT1.1. This includes the
ExxER/K motif on TM1 and TM4 and the glutamate on
TM10. Interestingly, the ExxER/K motif is also required
for glucosinolate transport via NPF2.11 [40]. Taken
together the current evidence suggests that specificity
within the POT family most likely resides in the extra-
cellular gate region of the binding site, which is different
between diverse POT family members. Such a mecha-
nism would enable rapid evolution of different specificity,
whilst retaining an efficient proton driven transport mo-
tor.
NRT1.1 is also regulated by phosphorylation [41,42].
To date the only other transporter regulated at the
mechanistic level by phosphorylation is the human sero-
tonin transporter SERT [43]. NRT1.1 is able to switch
between a high and low KM state in response to phos-
phorylation at an intracellular threonine, Thr101. When
external nitrate concentrations are high (>1 mM)
NRT1.1 is unphoshorylated and held in a high KM state
(KM
app 10 mM), presumably to avoid saturation. Howev-
er, when nitrate levels in the external environment fall
below 1 mM, NRT1.1 is phosphorylated at Thr101, and
switched into a low KM state (KM
app < 1 mM), to scav-
enge the remaining nitrate. The recent crystal structure of
NRT1.1 revealed that Thr101 sits on TM3 and points
into a hydrophobic cavity formed by residues on TM2 and
TM4, which make up the extracellular and intracellular
gates respectively (Figure 1b). We proposed that phos-
phorylation of this residue would disrupt the packing
between these helices and enable NRT1.1 to cycle faster,
possibly lowering the energetic barrier for the return step
in the transport cycle [38]. This destabilization is also
linked to a dimer-monomer transition in the membrane
[39,44] and may have subsequent effects in regulating
the nitrate-signaling cascade that activates the high affin-
ity nitrate uptake system [45].
NRT1.1 is suggested to coordinate a network of pro-
tein–protein interactions in the membrane, regulating
the kinase CIPK23 that phosphorylates Thr101 and also
transcription  factors for the NRT2 family of high affin-
ity nitrate transporters [45]. Could something similar
be happening with PepT1 and PepT2? Unlike other
eukaryotic POT family members, PepT1 and PepT2
have a large 200 amino acid extracellular domain
inserted between TM9 and TM10. Recently the crystal
structure of the extracellular domain from the mamma-
lian peptide transporters has been reported and shows
two IgG-like domains linked in tandem (Figure 4c)
[46]. Removing these domains from PepT2 resulted
in no effect on peptide or drug uptake, suggesting theyCurrent Opinion in Structural Biology 2017, 45:17–24
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Eukaryotic POT family transporters. (a) Crystal structure of NRT1.1 bound to nitrate (PDB:5A2O & 4OH3). The binding pocket for nitrate is shown
coloured according to the electrostatic properties of the side chains. The principle nitrate binding residue, H356, is shown. The intracellular gate
helices, TM 4 & 5 are coloured cyan, with Thr101 shown as sphered in magenta. (b) Close up view of the position of Thr101 in relation to the
intracellular gate. (c) Crystal structure of the extracellular domain of rat PepT2 (PDB:5A9H), showing overall dimensions. (d) Hybrid model of
human PepT1 showing the location of the extracellular and trans membrane domains. A model of trypsin has been docked in the putative
interaction site.were incorporated to add functionality. Biochemical
evidence showed a specific interaction with the intesti-
nal protease trypsin through a conserved electrostatic
patch on the surface of the domain. Such an interaction
would be highly novel and suggest that PepT1 and
PepT2 may act within a protein network at the plasma
membrane. Using this crystal structure and a homology
model of the trans membrane domain built from the
bacterial and plant members, a hybrid model of the
mammalian transporter can be built and the trypsin
molecule modeled at the interaction site (Figure 4d).
The model shows how the extracellular domain would
sit in relation to the transport domain, and makes a role
for the extracellular domain in protein-protein interac-
tions a distinct possibility.Current Opinion in Structural Biology 2017, 45:17–24 Conclusion
The POT family provides a number of puzzles for
biochemists and pharmacologists alike. How has one
binding site adapted to recognize such a diverse range
of substrates and can we utilize this knowledge to
improve drug uptake in the human body? How does
the POT family couple transport to protons and is there
a conserved mechanism? How are the family regulated in
eukaryotes, and are they part of more complicated nutri-
ent uptake systems yet to be discovered? It will take a
number of additional studies to address these questions
in full, however the current success of structural and
biochemical studies have provided fresh impetus into
previous physiology based approaches to study these
transporters.www.sciencedirect.com
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here support an important role for the interaction of
peptide side chains with the specificity pockets in the
binding site. Differences in peptide specificity observed
between bacterial POT family homologues suggest that
in bacteria POT transporters have evolved to preferen-
tially recognize distinct subsets of peptides, be they polar,
hydrophobic, acidic or basic. Indeed, many bacterial
species contain several POT family homologues, most
probably with each adapted to recognize and transport a
specific set of peptides. However, mammals contain only
two POT family transporters, suggesting that our trans-
porters have found a way to increase specificity over their
bacterial counterparts. The trade offs made, in terms of
efficiency and mechanism however, will require further
study to understand, especially with respect to drug and
pro-drug transport in the small intestine.
Finally, the recent elucidation of the crystal structures of
NRT1.1 and the extracellular domains of PepT1 and
PepT2 demonstrate two different ways that POT family
members have adapted to the work in higher eukaryotes.
It will be interesting to see if, like the plant NRT1.1, the
mammalian members of this family also play a role in
nutrient sensing and metabolic regulation.
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